Items where authors include "Drevinek, P."

Article

Keating, C., Yonker, L.M., Vermeulen, F. et al. (320 more authors) (2025) Vanzacaftor–tezacaftor–deutivacaftor versus elexacaftor–tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials. The Lancet Respiratory Medicine, 13 (3). pp. 256-271. ISSN 2213-2600

Burgel, P.-R., Ballmann, M., Drevinek, P. et al. (8 more authors) (2024) Considerations for the use of inhaled antibiotics for Pseudomonas aeruginosa in people with cystic fibrosis receiving CFTR modulator therapy. BMJ Open Respiratory Research, 11 (1). e002049. ISSN 2052-4439